Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4143/crt.2014.074 http://scihub22266oqcxt.onion/10.4143/crt.2014.074 C4614188!4614188!25672588     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cancer+Res+Treat 2015 ; 47 (4): 823-33 Nephropedia Template TP {{tp|p=25672588|t=2015. APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer |pdf=|usr=}}{{25672588}} gab.com Text APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer JO: Cancer Res Treat http://www.kidney.de/pget.php?&tw=1&pmid=25672588 #FOAvip Purpose: Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is a multifunctional protein that shows elevated expression in a number of cancers. We attempted to determine whether serum APE1/Ref-1 is elevated in patients with bladder cancer. Materials and Methods: Serum APE1/Ref-1 levels were determined using enzyme-linked immunosorbent assay in serum from patients with bladder cancer who had not received chemotherapy or radiotherapy (n=51) and non-tumor controls (n=55). The area under the receiver operating characteristic area under the curve was applied to determine the correlation between clinical factors and the serum levels of APE1/Ref-1. Results: Serum levels of APE1/Ref-1 in bladder cancer patients were significantly elevated compared to those of the control group (3.548±0.333 ng/100 ?L [n=51] for bladder cancer vs. 1.547±0.319 ng/100 ?L [n=55] for the control group), with a sensitivity and specificity of 93% and 59%, respectively. Serum APE1/Ref-1 levels are associated with tumor stage, grade, muscle invasion, and recurrence. Conclusion: Serum APE1/Ref-1 might be useful as a potential serologic biomarker for bladder cancer. Twit Text FOAVip APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer ????Cancer Res Treat http://www.kidney.de/pget.php?&tw=1&pmid=25672588 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25672588 #FOAvip English Wikipedia <ref>{{Cite pmid|25672588}}</ref> APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer #MMPMID25672588 Shin JH; Choi S; Lee YR; Park MS; Na YG; Irani K; Lee SD; Park JB; Kim JM; Lim JS; Jeon BH Cancer Res Treat 2015[Oct]; 47 (4): 823-33 PMID25672588show ga Purpose: Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is a multifunctional protein that shows elevated expression in a number of cancers. We attempted to determine whether serum APE1/Ref-1 is elevated in patients with bladder cancer. Materials and Methods: Serum APE1/Ref-1 levels were determined using enzyme-linked immunosorbent assay in serum from patients with bladder cancer who had not received chemotherapy or radiotherapy (n=51) and non-tumor controls (n=55). The area under the receiver operating characteristic area under the curve was applied to determine the correlation between clinical factors and the serum levels of APE1/Ref-1. Results: Serum levels of APE1/Ref-1 in bladder cancer patients were significantly elevated compared to those of the control group (3.548±0.333 ng/100 ?L [n=51] for bladder cancer vs. 1.547±0.319 ng/100 ?L [n=55] for the control group), with a sensitivity and specificity of 93% and 59%, respectively. Serum APE1/Ref-1 levels are associated with tumor stage, grade, muscle invasion, and recurrence. Conclusion: Serum APE1/Ref-1 might be useful as a potential serologic biomarker for bladder cancer. äAPE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Can(epmc).pdf DeepDyve Pubget Overpricing